More on the 4th case of PML in a pwMS on Tecfidera

Rumours about a 4th case of PML in a 61 year old MSer have been confirmed. What is not mentioned in the report is whether Tysabri played a role, but I suspect it didn't given the potential benefit for Biogen's share price of blaming natalizumab instead of Tecfidera.